374 related articles for article (PubMed ID: 26015453)
1. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure.
Schwartzman M; Reginensi A; Wong JS; Basgen JM; Meliambro K; Nicholas SB; D'Agati V; McNeill H; Campbell KN
J Am Soc Nephrol; 2016 Jan; 27(1):216-26. PubMed ID: 26015453
[TBL] [Abstract][Full Text] [Related]
2. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
[TBL] [Abstract][Full Text] [Related]
3. Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis.
Zhuang Q; Li F; Liu J; Wang H; Tian Y; Zhang Z; Wang F; Zhao Z; Chen J; Wu H
Lab Invest; 2021 Feb; 101(2):258-270. PubMed ID: 33203894
[TBL] [Abstract][Full Text] [Related]
4. The role of the FSGS disease gene product and nuclear pore protein NUP205 in regulating nuclear localization and activity of transcriptional regulators YAP and TAZ.
Ester L; Cabrita I; Ventzke M; Kieckhöfer E; Christodoulou M; Mandel AM; Diefenhardt P; Fabretti F; Benzing T; Habbig S; Schermer B
Hum Mol Genet; 2023 Nov; 32(22):3153-3165. PubMed ID: 37565816
[TBL] [Abstract][Full Text] [Related]
5. ARHGEF7 (
Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T
J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698
[TBL] [Abstract][Full Text] [Related]
6. Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGS.
Maezawa Y; Onay T; Scott RP; Keir LS; Dimke H; Li C; Eremina V; Maezawa Y; Jeansson M; Shan J; Binnie M; Lewin M; Ghosh A; Miner JH; Vainio SJ; Quaggin SE
J Am Soc Nephrol; 2014 Nov; 25(11):2459-70. PubMed ID: 24904088
[TBL] [Abstract][Full Text] [Related]
7. Nuclear YAP localization as a key regulator of podocyte function.
Bonse J; Wennmann DO; Kremerskothen J; Weide T; Michgehl U; Pavenstädt H; Vollenbröker B
Cell Death Dis; 2018 Aug; 9(9):850. PubMed ID: 30154411
[TBL] [Abstract][Full Text] [Related]
8. Growth-dependent podocyte failure causes glomerulosclerosis.
Fukuda A; Chowdhury MA; Venkatareddy MP; Wang SQ; Nishizono R; Suzuki T; Wickman LT; Wiggins JE; Muchayi T; Fingar D; Shedden KA; Inoki K; Wiggins RC
J Am Soc Nephrol; 2012 Aug; 23(8):1351-63. PubMed ID: 22773827
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated nephropathy: experimental models.
Avila-Casado C; Fortoul TI; Chugh SS
Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
[TBL] [Abstract][Full Text] [Related]
10. RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signal.
Huang Z; Zhang L; Chen Y; Zhang H; Yu C; Zhou F; Zhang Z; Jiang L; Li R; Ma J; Li Z; Lai Y; Lin T; Zhao X; Zhang Q; Zhang B; Ye Z; Liu S; Wang W; Liang X; Liao R; Shi W
BMC Nephrol; 2016 Jul; 17(1):66. PubMed ID: 27389190
[TBL] [Abstract][Full Text] [Related]
11. Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.
Campbell KN; Tumlin JA
Am J Nephrol; 2018; 47 Suppl 1(Suppl 1):14-29. PubMed ID: 29852493
[TBL] [Abstract][Full Text] [Related]
12. Yes-associated protein (YAP) promotes cell survival by inhibiting proapoptotic dendrin signaling.
Campbell KN; Wong JS; Gupta R; Asanuma K; Sudol M; He JC; Mundel P
J Biol Chem; 2013 Jun; 288(24):17057-62. PubMed ID: 23667252
[TBL] [Abstract][Full Text] [Related]
13. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
[TBL] [Abstract][Full Text] [Related]
14. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
Raij L; Tian R; Wong JS; He JC; Campbell KN
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
[TBL] [Abstract][Full Text] [Related]
15. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
[TBL] [Abstract][Full Text] [Related]
16. Nephrin is necessary for podocyte recovery following injury in an adult mature glomerulus.
Verma R; Venkatareddy M; Kalinowski A; Li T; Kukla J; Mollin A; Cara-Fuentes G; Patel SR; Garg P
PLoS One; 2018; 13(6):e0198013. PubMed ID: 29924795
[TBL] [Abstract][Full Text] [Related]
17. Proteome Analysis of Isolated Podocytes Reveals Stress Responses in Glomerular Sclerosis.
Koehler S; Kuczkowski A; Kuehne L; Jüngst C; Hoehne M; Grahammer F; Eddy S; Kretzler M; Beck BB; Höhfeld J; Schermer B; Benzing T; Brinkkoetter PT; Rinschen MM
J Am Soc Nephrol; 2020 Mar; 31(3):544-559. PubMed ID: 32047005
[TBL] [Abstract][Full Text] [Related]
18. FSGS as an Adaptive Response to Growth-Induced Podocyte Stress.
Nishizono R; Kikuchi M; Wang SQ; Chowdhury M; Nair V; Hartman J; Fukuda A; Wickman L; Hodgin JB; Bitzer M; Naik A; Wiggins J; Kretzler M; Wiggins RC
J Am Soc Nephrol; 2017 Oct; 28(10):2931-2945. PubMed ID: 28720684
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury.
Chen J; Wang X; He Q; Yang HC; Fogo AB; Harris RC
Kidney Int; 2024 Jun; 105(6):1200-1211. PubMed ID: 38423183
[TBL] [Abstract][Full Text] [Related]
20. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
